Covid updates: Guidelines for schools, India's first low-cost test & more

The Drugs Controller General of India has approved of the commercial launch of 'Feluda', the Tata CRISPR Covid-19 test

Coronavirus testing

1 min read Last Updated : Sep 21 2020 | 1:19 PM IST

After recording more than 90,000 Covid-19 cases consecutively for five days, on Sunday, India witnessed around 87,000 new cases.

The Drugs Controller General of India has approved of the commercial launch of ‘Feluda’, the Tata CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) Covid-19 test.

Tune in to the podcast for more

Also Read

The nitty-gritty of renovating your house to make it Covid-compliant

Covid-19: India tops 5 mn cases, Trump talks of 'herd mentality', & more

Work from home norms to vaccine updates: Covid highlights of last 24 hours

Covid-19 patients can now opt for home isolation: Here're govt guidelines

World Coronavirus Dispatch: EU slams China over fake Covid-19 info

Topics :Coronavirus Coronavirus Tests Coronavirus Vaccine United Nations Health Ministry

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Sep 21 2020 | 1:12 PM IST